New Genedata Screener Presented at CHI High Content Analysis Conference

Share Article

Screener 9 delivers an enterprise hub for HCS data, linking multiple instruments and image management systems to create cost efficiencies and improved productivity.

With ten years of best practices built-in and five years specifically supporting high content data, Screener 9 is a proven enterprise hub for all plate-based screening data, with unmatched support for HCS data analysis

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced a new version of Genedata Screener®, a comprehensive software system for high content data analysis. Screener version 9 celebrates ten years of industry leadership in delivering cost-efficient screening data management. It features an enhanced user interface for simultaneous processing of multiple dose-response curve assays and high content image display across the entire screening cascade. These features advance the speed and accuracy of all plate-based screening at pharmaceutical companies, specialized contract research organizations, and academic screening centers. Out-of-the-box integration with leading image store solutions creates a cost-efficient HCS data management infrastructure. Genedata, a sponsor of Cambridge Healthtech Institute’s 8th Annual High Content Analysis conference, will demonstrate the new Genedata Screener at Booth 28 (January 11 – 14; Fairmont Hotel).

“HCS has come of age. It has evolved from the domain of scientific experts to a broad application in life science research, which is fueled by a larger portfolio of affordable instruments and easier-to-use image analysis packages specific to experimental needs,” noted Dr. Othmar Pfannes, CEO of Genedata. “Genedata Screener 9 addresses this market shift with innovations in integration and visualization.

“With ten years of best practices built-in and five years specifically supporting high content data, Screener 9 is a proven enterprise hub for all plate-based screening data, with unmatched support for HCS data analysis,” continued Pfannes. “It integrates across instruments as well as HCS image analysis packages and image management systems. This integration plus enhanced visualization capabilities help to standardize and extend HCS data analysis across an organization while improving productivity without increasing data analysis cost.”

Innovations in Visualization and Integration
A modular system that supports the complete hit-to-lead process on a single platform, Genedata Screener scales from single plates to screens of millions of compounds. All industry-standard screening result calculations are incorporated into the system, which creates a single access point to data and images for downstream applications.

Genedata Screener 9 brings improved HCS image access and display with on-demand drill-down to original HCS images during dose-response analysis. New visualizations display complex images from multi-channeled HCS experiments including composites, masks, and overlays. They serve the in-depth qualification and systematic analysis of compound effects on cellular phenotypes. Specific enhancements include:

  • High Content Analyzer now integrates with all the leading image storage solutions including PerkinElmer® Columbus® Image Data Management and Analysis System and Thermo Scientific Store database. Integration is also in active development with industry leaders such as the Molecular Devices MDCStore™ Data Management Solution.
  • Condoseo now manages multiple dose-dependent HCS features in parallel and displays original HCS images alongside the dose-response curves. Its dockable user interface makes navigation easy among multiple assays, and it allows simultaneous processing of multiple assays, fitting hundreds to thousands of high-quality dose-response curves in seconds.
  • Kinetics Analyzer now imports data from all time-resolved screening instruments, including label-free and automated electrophysiology experiments, and provides interactive access to kinetics traces as well as custom curve analysis methods.

Genedata Screener version 9 is available now and shipping directly from Genedata.

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery and life science research, which spans target, lead and biomarker discovery. Used by a majority of the world’s top 50 pharmaceutical companies and leading research organizations, Genedata Phylosopher®, Genedata Screener®, Genedata Expressionist®, Genedata Analyst™, and Genedata Selector™ make research data accessible and understandable, enabling scientific discovery that fights disease and improves health worldwide. Founded in 1997, Genedata is privately held, with headquarters in Basel, Switzerland, and offices in Japan, Germany and the US.

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Allison Kurz
+41 61 511 8459
Email >

Jackie Thrasivoulos
+1 508 881 3109
Email >
Visit website